Whalegun
Home

David Malcom Rodman, Chief Medical Officer: Mineralys Therapeutics MLYS Sell · Filed 03/17

Trade details

Type
Insider sale
Amount
$10,696.05
Shares · price
417 sh · $25.65 a share
Held after
76,140 sh
Stock
Mineralys Therapeutics MLYS
Person
David Malcom RodmanChief Medical Officer
Trade date
26/03/17
Filed
26/03/17
Days to filing
0 days

Sold 0.5% of holdings

Share of holding sold
0.5%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 02/15~04/16

David Malcom Rodman's recent trades

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $11.7K

    Filed 09/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $216.9K

    Filed 09/14

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $67K

    Filed 09/09

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $10.6K

    Filed 08/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $372.2K

    Filed 08/13